Marathon Capital Management’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Marathon Capital Management’s Portfolio SRGA Stock Details SRGA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-333	Closed	–	–	100
2016 Q2	$0	Hold	333	–	–	﹤0.01%	99
2016 Q1	$0	Hold	333	–	–	﹤0.01%	97
2015 Q4	$39K	Hold	333	–	–	0.02%	83
2015 Q3	$0	Hold	333	–	–	﹤0.01%	99
2015 Q2	$0	Hold	333	–	–	﹤0.01%	103
2015 Q1	$0	Hold	333	–	–	﹤0.01%	97
2014 Q4	$0	Hold	333	–	–	﹤0.01%	94
2014 Q3	$48K	Buy	+333	New	+$48.3K	0.04%	86
2014 Q2	–	Sell	-667	Closed	-$82K	–	93
2014 Q1	$82K	Sell	667 -20,461	-97%	-$2.22M	0.06%	85
2013 Q4	$2.24M	Buy	21,128 +296	+1%	+$28.7K	1.62%	20
2013 Q3	$2.34M	Sell	20,832 -683	-3%	-$77.5K	2.01%	18
2013 Q2	$2.43M	Buy	+21,515	New	+$2.63M	2.07%	18

Other funds holding SRGA

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

GCP

Glen Capital Partners Waltham, Massachusetts $68.9M AUM 21.81% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hillman Company Pittsburgh, Pennsylvania $257M AUM 26.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Marathon Capital Management's SRGA Position: Q3 2016 in Review

Marathon Capital Management sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q3 2016, closing a stake of 333 shares.

Marathon Capital Management first reported a position in SRGA in Q2 2013 and held it in 12 quarters. The position peaked at $2.43M in Q2 2013. 110 funds tracked by Wall St. Rank hold SRGA as of Q3 2016.

Marathon Capital Management reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
Marathon Capital Management sold 333 Surgalign Holdings, Inc. Common Stock shares in Q3 2016.
Marathon Capital Management first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 12 quarters.
Marathon Capital Management's Surgalign Holdings, Inc. Common Stock position peaked at $2.43M in Q2 2013.
110 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q3 2016.

Based on Marathon Capital Management's 13F filing for Q3 2016, filed 10 Nov 2016.